Select a Region North America

Meet EVERSANA at WODC 2023

EVERSANA is a proud to sponsor the World Orphan Drug Congress USA held at the Gaylord National Resort and Convention Center in Washington, DC May 23-25. Visit our booth or schedule a meeting with EVERSANA’s experts in rare diseases, patient services, data and analytics and commercialization services to learn how EVERSANA leads the way in simplifying complex rare disease patient journeys.

EVERSANA’s Rare Disease Expertise
With over 7,000 distinct rare and genetic diseases affecting 400+ million individuals, the average time to diagnosis still remains approximately 7 years. In response, EVERSANA’s end-to-end commercialization platform provides manufacturers innovative solutions to accelerate speed to market, diagnose patients faster, simplify new therapy onboarding and personalize adherence support.

Speaking Sessions Featuring EVERSANA Experts on Wednesday, May 24

Keynote Panel: Digital Transformation for Rare Disease​s – What’s working and what needs to change?  |  1:00-1:40 PM

  • Maria Kirsch, President, Patient Services
  • Scott Snyder, Chief Digital Officer

Panel: Use of Real-World Data for Rare Diseases  |  11:50-12:10 PM

  • Scott Snyder, Chief Digital Officer
  • Pierantonio Russo, MD, Chief Medical Officer

Panel: Expediating Rare Diseases Diagnosis  3:00-3:20 PM

  • Pierantonio Russo, MD, Chief Medical Officer

Panel: Commercializing Orphan Products for Rare Diseases  |  4:00-4:40 PM

  • Faruk Abdullah, President, Professional Services and Chief Business Officer

Read Our Latest Thinking on Rare Disease Commercialization

Learn More About EVERSANA


Surrounded by best-in-class field deployment, agency, channel management and more. Explore more: 

  • Patient Services (link to functional details further below on the page) 
  • Field Deployment & Field Medical 
  • Distribution and Channel Management 
  • Creative and Digital Agency with specialization in Market Access 


EVERSANA has reinvented commercialization in the pharmaceutical space. We work with large pharma to optimize the last few years of established brands – making the most out of revenue potential. We are working with emerging biotech to launch their first products – delivering unparalleled agility to navigate market complexities and drive down costs – up to 20% if they had to commercialize on their own.  

  • Operational Rigor 
  • Integrated Services  
  • Optimized by Analytics 


We understand the needs and sophistication of complex therapies. Our award-winning commercialization models were developed to be agile, flexible, cost effective and to lower the risk of uncertainty. They are digital first and powered by data, analytics and AI.  

  • Agility to pivot strategies without “change order” mentality 
  • Speed to market 
  • Risk management 
  • Owners maintain full value of their asset 

Visit our booth schedule a meeting with EVERSANA’s rare disease experts today.